Trupanion CEO Margaret Tooth sells $25,840 in company stock

Trupanion CEO Margaret Tooth sold 1,000 shares of the company's stock on October 9, 2026, at a price of $25.84 per share, totaling $25,840. The stock's price has since increased to $26.57, marking a 7.7% gain over the past week. Analysts at InvestingPro believe the stock is undervalued, with a PEG ratio of 0.44 indicating good value given its growth potential.

Following this transaction, Tooth now owns 184,952 shares of Trupanion common stock. This sale was carried out according to a Rule 10b5-1(c) trading plan Tooth put in place on May 11, 2026, for financial diversification purposes. The company reported stronger-than-expected Q2 2026 earnings, with per-share earnings of $0.16, surpassing the forecasted $0.1133, and revenue increasing by 11% to $392.9 million.

Despite this positive performance, Piper Sandler downgraded Trupanion to Neutral, citing economic uncertainties, and reduced its price target from $45 to $32. Stifel, on the other hand, increased its price target to $29, maintaining a Hold rating. Notably, Trupanion plans to cease its partnership with Pets Best by the end of Q3 2028, which may result in a decrease in enrollment.